United States: California Court Of Appeal Affirms New Trial In Talc Case

Last Updated: August 7 2019
Article by Steven Boranian

The California Court of Appeal has finally filed its opinion in the much-discussed talc ovarian cancer case, Echeverria v. Johnson & Johnson, No. B286283, 2019 WL 3001626 (Cal. Ct. App. July 9, 2019), and while it is not a complete win for the defense, it was close, and there is much to talk about. As we reported to you in detail here, this is the case where a Los Angeles jury returned a $417 million verdict against a cosmetic talc manufacturer and its holding company, despite hearing no substantial evidence against the holding company and hopelessly unreliable expert opinions on specific causation. The trial court entered judgment notwithstanding the verdict for both defendants on the basis that there was no substantial evidence to support the verdict and alternatively granted their motion for a new trial. Regarding the new trial order, we wrote,

You might wonder why the court granted a motion for new trial when it had already granted the motions for judgment notwithstanding the verdict and entered judgment in the defendants' favor. The reason is the inevitable appeal. If the California Court of Appeal reverses the order granting JNOV for either defendant, it can still affirm the order granting a new trial and remand the parties to try the case again, rather than reinstate the original verdict. [¶] Let's hope it does not come to that . . . .

Well, it sort of came to that, but not completely. The Court of Appeal affirmed the JNOV for the holding company, affirmed the JNOV in favor of the manufacturer on punitive damages, reversed the JNOV for the manufacturer on compensatory liability, and affirmed the order granting a new trial.

So where does that leave the parties? If the result stands (the time for rehearing has not expired), then they go back to the trial court for a trial on the manufacturer's compensatory liability only. No holding company and no punitive damages. Let's take a closer look at how they got there.

The holding company's motion for judgment notwithstanding the verdict. The case against the holding company never should have gone to the jury in the first place, and the Court of Appeal had no difficulty affirming the JNOV. There was simply no evidence, let alone substantial evidence, that the holding company breached a duty to warn—either before or after 1967, the year the plaintiff claimed the holding company last made the product. The Court of Appeal rejected the plaintiff's citation to T.H. v. Novartis Pharmaceuticals Corp., 4 Cal. 5th 145, 164 (2017), where the California Supreme Court held that an innovator drug manufacturer can be liable for injuries caused by a generic version of the same product, even after the innovator has stopped selling the drug. According to the Court of Appeal, the reasoning of T.H. v. Novartis is "inextricably tied to the 'distinctive legal framework governing labeling for brand-name and generic pharmaceuticals.'" Echeverria, 2019 WL 3001626, at *15. For talc, the Court of Appeal applied "the general rule that a manufacturer has no duty to warn of risks posed by another manufacturer's product." Id. (citing O'Neil v. Crane Co., 53 Cal. 4th 335, 364-66 (2012)). This is clearly the correct result, and we like any cabining of the wrongly decided T.H. v. Novartis opinion that we can get.

The manufacturer's motion for judgment notwithstanding the verdict. As we said in our prior post, it's all about the experts, and that is how it played out on appeal, too. We knew where the Court of Appeal's opinion was going when it spent page after page setting forth the experts' opinions and the various documents and articles upon which they relied. Recall that the standard for granting (and affirming) a judgment notwithstanding the verdict is that, viewing the evidence in the light most favorable to the party securing the verdict, there is no substantial evidence to support the verdict. The Court of Appeal took great pains to lay out the evidence viewed "in the light most favorable" to the plaintiff, id. at *4-*12, and we understand its obligation to do so under the standard of review.

We disagree, however, with the Court's conclusion that substantial evidence supported the plaintiff's verdict. Although the Court described myriad documents purporting to discuss talc use and potential disease, it remains undisputed that "no published studies, regulatory agencies, or scientific organizations have concluded talc-based inflammation causes ovarian cancer." It is likewise undisputed that "there has not been direct, conclusive evidence establishing genital talc use causes ovarian cancer." Id. at *2, *26. That is pretty strong stuff, and it should be dispositive in favor of the defense.

We also disagree with the Court of Appeal's treatment of the "differential diagnosis" offered by the plaintiff's only specific causation expert, the plaintiff's treating physician. Id. at *20-*25. The trial court ruled correctly that the expert has not properly "ruled in" talc as a potential cause of ovarian cancer. The Court of Appeal discarded that ruling on the basis that the trial court had combined "two distinct methods of proving specific causation—the use of epidemiological studies alone and the use of a differential etiology." Id. at *19 n.12. We don't think the trial court was confused at all. The trial court examined studies that the plaintiff's experts cited; it concluded that the studies on their faces could not "rule in" talc as a potential cause (and that some actually tended to disprove causation); and it rejected the expert's differential diagnosis as unreliable. We again understand that the standard of review requires viewing the evidence most favorable to the plaintiff, but that does not deprive the trial court the prerogative to determine what expert testimony is reliable (and therefore admissible) and what is not.

The motions for judgment notwithstanding the verdict on punitive damages. The Court of Appeal's careful exposition of the evidence inured to the defendants' benefit when addressing punitive damages, on which the Court affirmed JNOV. In short, not only is there no "conclusive evidence establishing genital talc use causes ovarian cancer," it is not widely accepted in the medical community that talc is even a significant risk factor for ovarian cancer. Id. *26. The plaintiff's specific causation expert did not warn her patients about genital talc use and ovarian cancer until this litigation, and her epidemiology expert chaired a committee that found in 2006 that the evidence was insufficient to conclude that perineal use of talc caused ovarian cancer. Id. In other words, "[t]here was no substantial evidence to support a finding, by clear and convincing evidence, of despicable conduct which [the manufacturer] carried out with a willful and conscious disregard of the safety of others." Id.

The motion for new trial. The portion of the opinion affirming a new trial boils down to the standard of review. While judgment as a matter of law is judged under a "substantial evidence," standard, a judge deciding a motion for new trial sits as "thirteenth juror" and is permitted to weigh the evidence, draw inferences, and determine whether the evidence is sufficient to support the verdict or whether a new trial is warranted. Id. at *28. Given the state of the evidence, the Court of Appeal found no abuse of discretion in granting a new trial because "the evidence at trial would have supported a verdict in [the manufacturer's] favor." Id. at *30.

The result is not a complete defense win, but any new trial will proceed without the holding company (and its presumably robust net worth), without punitive damages, and likely with greater scrutiny of what the plaintiff's experts will be allowed to say to the jury. This of course will not be the last word in talc-related litigation.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions